<DOC>
	<DOCNO>NCT01688843</DOCNO>
	<brief_summary>The objective study gather data establish safety , performance effectiveness INGEVITY pace/ sense lead .</brief_summary>
	<brief_title>Safety Performance Study INGEVITY Lead</brief_title>
	<detailed_description />
	<mesh_term>Bradycardia</mesh_term>
	<mesh_term>Sick Sinus Syndrome</mesh_term>
	<criteria>Subject willing capable providing inform consent Subject Class I II indication implantation single ( VVI ( R ) ) dual chamber pacemaker CRTP system accord ACC/AHA/HRS , ESC guideline Subject willing capable participate testing/ visit associate clinical study approve clinical study center interval define protocol Subject age 18 , legal age give inform consent specific state national law Subject pace ICD system implant Subject sensitivity dexamethasone acetate ( DXA ) Subject mechanical tricuspid heart valve Subject enrol concurrent study , exception local mandatory governmental registry observational studies/registries Subjects document permanent persistent AF physician intend implant dual chamber pulse generator ( single chamber VVIR pulse generator subject acceptable ) Subject currently active heart transplant list Subject document life expectancy le 12 month Women childbearing potential might pregnant time study enrollment INGEVITY Lead implant Subjects currently require dialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>bradycardia</keyword>
	<keyword>sinus node dysfunction</keyword>
</DOC>